
Researchers ready lab-grown Covid-19 Delta variant for human trials
While the rest of the world is trying to stamp out the Covid-19 Delta variant, British researchers are making progress growing a carefully controlled batch in a lab that they hope
While the rest of the world is trying to stamp out the Covid-19 Delta variant, British researchers are making progress growing a carefully controlled batch in a lab that they hope
Venn Data Management services/capabilities span the data life cycle from collection to archival. Data drives the whole clinical development process. A high-quality dataset is therefore essential for the success of
Dublin-listed pharmaceutical services company Open Orphan said its subsidiary hVivo has signed an £8.1 million (€9.5 million) asthma contract with a major pharmaceutical firm to test an inhaled human rhinovirus
Open Orphan plc (LON:ORPH), a rapidly growing specialist contract research organisation and world leader in vaccine and antiviral testing using human challenge clinical trials, has announced that hVIVO, a subsidiary
In order to ensure a good development trajectory for your potential drug compound a good understanding of the drug development process is indispensable. Each step in the process is linked
Dublin-listed pharmaceutical services company Open Orphan has announced that its subsidiary, Hvivo, has developed a controlled human malaria infection challenge model. In virus challenge studies, healthy volunteers are administered a
Open Orphan plc (LON:ORPH), a rapidly growing specialist clinical research organisation and world leader in testing vaccines and antivirals using human challenge clinical trials, has announced that its subsidiary, hVIVO,
A well thought out and specific project management approach The project management of early development (phase 1 / 2a) trials requires a well thought and specific approach. Phase 1 trials
Venn Life Sciences has been part of the Open Orphan PLC Group since 2019. The Open Orphan group includes several companies that specialise in drug development. The two largest companies
Non-clinical testing is conducted throughout all phases of drug development to assess the safety profile and pharmacokinetic/toxicokinetic (PK/TK) characteristics of drug candidates. If performed well, it can identify key ‘knock-out’